I 

117TH CONGRESS 

1ST SESSION H. R. 1176 

To amend title XXVII of the Public Health Service Act to require group 

health plans and health insurance issuers offering group or individual 

health insurance coverage to provide coverage for prostate cancer 

screenings without the imposition of cost-sharing requirements, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 18, 2021 

Mr. RUSH (for himself and Mr. BUCSHON) introduced the following bill; which 

was referred to the Committee on Energy and Commerce 

A BILL 

To amend title XXVII of the Public Health Service Act 

to require group health plans and health insurance 

issuers offering group or individual health insurance coverage to provide coverage for prostate cancer screenings 

without the imposition of cost-sharing requirements, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Prostate-Specific Anti5 gen Screening for High-risk Insured Men Act’’ or the 

6 ‘‘PSA Screening for HIM Act’’. 


khammond on DSKJM1Z7X2PROD with BILLS
2 

•HR 1176 IH

1 SEC. 2. FINDINGS. 

2 Congress finds the following: 

3 (1) Prostate cancer is the second leading cause 

4 of cancer death in men in the United States with 1 

5 in 41 men dying from prostate cancer and more 

6 than 31,600 men estimated to die from prostate 

7 cancer in 2019. 

8 (2) Prostate cancer is the second most com9 monly diagnosed cancer in the Nation with 1 in 9 

10 men being diagnosed in their lifetimes, 3.1 million 

11 men in the United States living with a diagnosis, 

12 and over 174,000 men estimated to be diagnosed in 

13 2019. 

14 (3) The survival rate for prostate cancer diag15 nosed in early stage is near 100 percent but prostate 

16 cancer diagnosed in late stage has only a 30-percent 

17 survival rate. 

18 (4) There are few, if any, symptoms of prostate 

19 cancer before it reaches late stage. 

20 (5) African-American men have a disproportion21 ately higher rate of prostate cancer and are 70 per22 cent more likely to be diagnosed with prostate can23 cer than White men, with 1 in 6 African-American 

24 men developing prostate cancer in their lifetimes. 

25 (6) African-American men are 2.3 times more 

26 likely to die from prostate cancer than White men. 


khammond on DSKJM1Z7X2PROD with BILLS
3 

•HR 1176 IH

1 (7) Men with a father or brother with prostate 

2 cancer are more than twice as likely to be diagnosed 

3 with prostate cancer than men without a family his4 tory. 

5 (8) The common clinical definition for men at 

6 high-risk of prostate cancer includes African-Amer7 ican men and men with a family history. 

8 (9) Most of the major cancer and urological so9 cieties recommend beginning screening discussions 

10 earlier for African-American men and those with a 

11 family history of prostate cancer. 

12 (10) The United States Preventive Services 

13 Task Force has encouraged research on screening 

14 African-American men, including whether to screen 

15 African-American men at younger ages, and has 

16 identified this research as a high-priority cancer re17 search gap. 

18 (11) Barriers to screening should be minimized 

19 for high-risk men in order to catch asymptomatic 

20 prostate cancer before it metastasizes and the sur21 vival rate is dramatically reduced. 

22 (12) The cost of treating metastatic prostate 

23 cancer in the United States health care system is 

24 hundreds of millions of dollars more annually than 

25 the cost of treating localized, early-stage cancer. 


khammond on DSKJM1Z7X2PROD with BILLS
4 

•HR 1176 IH

1 SEC. 3. REQUIREMENT FOR GROUP HEALTH PLANS AND 

2 HEALTH INSURANCE ISSUERS OFFERING 

3 GROUP OR INDIVIDUAL HEALTH INSURANCE 

4 COVERAGE TO PROVIDE COVERAGE FOR 

5 PROSTATE CANCER SCREENINGS WITHOUT 

6 IMPOSITION OF COST-SHARING REQUIRE7 MENTS. 

8 (a) IN GENERAL.—Subsection (a) of section 2713 of 

9 the Public Health Service Act (42 U.S.C. 300gg–13) is 

10 amended to read as follows: 

11 ‘‘(a) COVERAGE OF PREVENTIVE HEALTH SERV12 ICES.— 

13 ‘‘(1) IN GENERAL.—A group health plan and a 

14 health insurance issuer offering group or individual 

15 health insurance coverage shall, at a minimum, pro16 vide coverage for and shall not impose any cost-shar17 ing requirements for— 

18 ‘‘(A) evidence-based items or services that 

19 have in effect a rating of ‘A’ or ‘B’ in the cur20 rent recommendations of the United States Pre21 ventive Services Task Force; 

22 ‘‘(B) immunizations that have in effect a 

23 recommendation from the Advisory Committee 

24 on Immunization Practices of the Centers for 

25 Disease Control and Prevention with respect to 

26 the individual involved; 


khammond on DSKJM1Z7X2PROD with BILLS
5 

•HR 1176 IH

1 ‘‘(C) with respect to infants, children, and 

2 adolescents, evidence-informed preventive care 

3 and screenings provided for in the comprehen4 sive guidelines supported by the Health Re5 sources and Services Administration; 

6 ‘‘(D) with respect to women, such addi7 tional preventive care and screenings not de8 scribed in subparagraph (A) as provided for in 

9 comprehensive guidelines supported by the 

10 Health Resources and Services Administration 

11 for purposes of this subparagraph; and 

12 ‘‘(E) with respect to men who are at high 

13 risk of developing prostate cancer (including Af14 rican-American men and men with a family his15 tory of prostate cancer (as defined in paragraph 

16 (2))), such additional preventive care and 

17 screenings not described in subparagraph (A) 

18 for prostate cancer. 

19 ‘‘(2) MEN WITH A FAMILY HISTORY OF PROS20 TATE CANCER DEFINED.—For purposes of para21 graph (1)(E), the term ‘men with a family history 

22 of prostate cancer’ means men who have a first-de23 gree relative— 

24 ‘‘(A) who was diagnosed with metastatic 

25 prostate cancer; 


khammond on DSKJM1Z7X2PROD with BILLS
6 

•HR 1176 IH

1 ‘‘(B) who developed metastatic prostate 

2 cancer; or 

3 ‘‘(C) whose death was a result of prostate 

4 cancer. 

5 ‘‘(3) CLARIFICATION REGARDING BREAST CAN6 CER SCREENING, MAMMOGRAPHY, AND PREVENTION

7 RECOMMENDATIONS.—For the purposes of this Act, 

8 and for the purposes of any other provision of law, 

9 the current recommendations of the United States 

10 Preventive Service Task Force regarding breast can11 cer screening, mammography, and prevention shall 

12 be considered the most current other than those 

13 issued in or around November 2009. 

14 ‘‘(4) RULE OF CONSTRUCTION.—Nothing in 

15 this subsection shall be construed to prohibit a plan 

16 or issuer from providing coverage for services in ad17 dition to those recommended by the United States 

18 Preventive Services Task Force or to deny coverage 

19 for services that are not recommended by such Task 

20 Force.’’. 

21 (b) EFFECTIVE DATE.—The amendment made by 

22 subsection (a) shall apply with respect to plan years begin23 ning on or after January 1, 2022. 

Æ 


khammond on DSKJM1Z7X2PROD with BILLS